Further evidence of developmental risks linked to epilepsy drugs in pregnancy

Study adds weight to previously reported risks and calls for monitoring of new antiseizure drugs Findings published by The BMJ today reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk for several other antiseizure ...

2026-03-12T09:56:41+00:0012 March 2026|Press release, The BMJ|

Stimulating international research dialogue on SGLT2 inhibitors and immune risk

The BMJ research: sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases In October 2025, The BMJ published the first nationwide population based cohort study to examine the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and risk of autoimmune rheumatic diseases (ARDs). Drawing on data from more than ...

2026-04-09T13:31:11+01:0027 February 2026|Corporate announcement, Our impact, The BMJ|

Many post-authorisation studies fail to comply with public disclosure rules 

Better adherence is required for greater research transparency, say researchers  Many post-authorisation studies registered with the European Medicines Agency (EMA) fail to comply with legal requirements and recommendations to make their findings public, finds a study published by The BMJ today. Post-authorisation studies (PAS) are carried out after a medicine is approved ...

2026-02-25T17:43:55+00:0026 February 2026|Press release, The BMJ|

HPV vaccination provides “sustained protection” against cervical cancer 

No indication of waning protection up to 18 years after vaccination, findings show Human papillomavirus (HPV) vaccination is associated with a significantly reduced risk of invasive cervical cancer, with no indication of waning protection up to 18 years after vaccination, finds a study from Sweden published by The BMJ today. HPV is one of the most ...

2026-02-25T17:39:42+00:0026 February 2026|Press release, The BMJ|

The BMJ teams up with top paediatric journals to enhance trial conduct and reporting 

The BMJ has teamed up with leading paediatric journals, JAMA Pediatrics and The Lancet Child & Adolescent Health, to co-publish two papers that will enhance trial conduct and reporting to improve the health of young patients and their families. The papers provide essential checklist items for researchers to include in clinical trial protocols and reports ...

2026-02-25T10:53:36+00:0025 February 2026|Corporate announcement, Partnership, Press release, The BMJ|

Mental health of children affected by armed conflict: experts call for global commitment and funding

New BMJ Collection calls for evidence based and sustainable mental health support in conflict settings A new collection on Child Mental Health in Conflict Settings published by The BMJ, in partnership with the World Innovation Summit for Health (WISH), calls for evidence based, scalable, sustainable, and long term interventions ...

2026-04-09T13:31:13+01:0024 February 2026|Collection, Corporate announcement, Launch, Our impact, Partnership, The BMJ|
Go to Top